Isadora Rosa

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 09, 2024
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes.

D Magalhaes, M Santiago, M Patita

|Jun 28, 2023
Inflammatory Bowel Disease Treatment in Cancer Patients-A Comprehensive Review.

Daniel Conceição, Margarida R Saraiva, Isadora Rosa

|Jun 15, 2023
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study.

Fernando Magro, Maria Manuela Estevinho, Gaia Catalano

|Dec 28, 2022
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease.

Samuel Raimundo Fernandes, Juliana Serrazina, Inês Ayala Botto

|May 22, 2020
Low rectal cancer treatment strategies: a cohort study assessing watch and wait.

João Cortez Pinto, António Dias Pereira, Ana Pimenta

Pageof 1

Frequent Collaborators

3 joint publications

Helena Tavares de Sousa

2 joint publications

Joana Roseira

2 joint publications

Laurent Peyrin-Biroulet

2 joint publications

Fernando Magro